Portfolio company
Nykode
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Nykode develops immunotherapy and vaccines for cancer and infectious diseases, targeting pharmaceutical companies through partnerships and licensing agreements.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Pharmexa A/S
This company develops active immunotherapy and peptide vaccines for patients with cancer, chronic illnesses, and infectious diseases.
IO Biotech
The company develops immune-modulating therapeutic cancer vaccines to treat patients with melanoma and other solid tumours.
Zymeworks
The company develops antibody-based biotherapeutics for cancer and inflammatory diseases, which it licenses to global pharmaceutical partners to treat patients.
Targovax AS (Oncos)
This biotechnology company develops circular RNA therapeutics and oncolytic virus-based immunotherapies for patients with solid tumours and other difficult-to-treat diseases.
Baseimmune
The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.
Themis Bioscience
This biotechnology company develops vaccines and immune-modulation therapies for infectious diseases and cancer to protect human populations from unmet medical needs.
Exomnis Biotech
This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.
